Amphastar Pharmaceuticals Net Profit Margin 2012-2024 | AMPH
Amphastar Pharmaceuticals net profit margin from 2012 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Amphastar Pharmaceuticals Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-06-30 |
$0.71B |
$0.17B |
23.28% |
| 2024-03-31 |
$0.68B |
$0.15B |
22.75% |
| 2023-12-31 |
$0.65B |
$0.14B |
21.24% |
| 2023-09-30 |
$0.60B |
$0.14B |
22.43% |
| 2023-06-30 |
$0.54B |
$0.10B |
18.85% |
| 2023-03-31 |
$0.52B |
$0.09B |
17.95% |
| 2022-12-31 |
$0.50B |
$0.09B |
18.27% |
| 2022-09-30 |
$0.48B |
$0.08B |
15.91% |
| 2022-06-30 |
$0.48B |
$0.09B |
19.12% |
| 2022-03-31 |
$0.46B |
$0.08B |
18.02% |
| 2021-12-31 |
$0.44B |
$0.06B |
14.38% |
| 2021-09-30 |
$0.41B |
$0.04B |
8.96% |
| 2021-06-30 |
$0.38B |
$0.01B |
2.86% |
| 2021-03-31 |
$0.37B |
$0.00B |
0.82% |
| 2020-12-31 |
$0.35B |
$0.00B |
0.57% |
| 2020-09-30 |
$0.34B |
$0.01B |
2.08% |
| 2020-06-30 |
$0.33B |
$0.00B |
1.20% |
| 2020-03-31 |
$0.33B |
$0.05B |
15.90% |
| 2019-12-31 |
$0.32B |
$0.05B |
15.22% |
| 2019-09-30 |
$0.33B |
$0.05B |
15.81% |
| 2019-06-30 |
$0.33B |
$0.05B |
16.31% |
| 2019-03-31 |
$0.32B |
$0.00B |
0.63% |
| 2018-12-31 |
$0.30B |
$-0.01B |
-2.03% |
| 2018-09-30 |
$0.27B |
$-0.01B |
-2.64% |
| 2018-06-30 |
$0.25B |
$-0.01B |
-3.64% |
| 2018-03-31 |
$0.24B |
$-0.00B |
-1.66% |
| 2017-12-31 |
$0.24B |
$0.00B |
1.67% |
| 2017-09-30 |
$0.24B |
0 |
0.00% |
| 2017-06-30 |
$0.25B |
$0.00B |
1.60% |
| 2017-03-31 |
$0.25B |
$0.01B |
3.56% |
| 2016-12-31 |
$0.26B |
$0.01B |
3.92% |
| 2016-09-30 |
$0.27B |
$0.02B |
7.84% |
| 2016-06-30 |
$0.27B |
$0.01B |
5.22% |
| 2016-03-31 |
$0.25B |
0 |
0.00% |
| 2015-12-31 |
$0.25B |
$-0.00B |
-1.19% |
| 2015-09-30 |
$0.23B |
$-0.01B |
-6.06% |
| 2015-06-30 |
$0.23B |
$-0.02B |
-7.05% |
| 2015-03-31 |
$0.22B |
$-0.01B |
-4.50% |
| 2014-12-31 |
$0.21B |
$-0.01B |
-5.21% |
| 2014-09-30 |
$0.21B |
$-0.01B |
-2.86% |
| 2014-06-30 |
$0.21B |
$-0.00B |
-0.48% |
| 2014-03-31 |
$0.22B |
$0.01B |
3.59% |
| 2013-12-31 |
$0.23B |
$0.01B |
5.22% |
| 2013-09-30 |
$0.23B |
$0.01B |
6.17% |
| 2013-06-30 |
$0.23B |
$0.02B |
7.56% |
| 2013-03-31 |
$0.21B |
$0.01B |
6.64% |
| 2012-12-31 |
$0.20B |
$0.02B |
8.82% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.469B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
